Advertisements


RedHill And Talicia: I Say Yes

RedHill And Talicia: I Say Yes.....»»

Category: topSource: seekingalphaNov 9th, 2018

RedHill Biopharma announces final patient assessed in Talicia study

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 24th, 2018

RedHill Biopharma reports completion of enrollment for Phase III Talicia study

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallSep 4th, 2018

RedHill announces enrollment of 300th patient in Phase III TALICIA study

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 4th, 2018

Cancer Research Highlight: RedHill Biopharma Sets Up Continued Invasion Into Cancer

Cancer Research Highlight: RedHill Biopharma Sets Up Continued Invasion Into Cancer.....»»

Category: topSource: seekingalphaNov 15th, 2018

RedHill Biopharma to present Yeliva data at EORTC-NCI-AACR Symposium

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallNov 14th, 2018

RedHill Biopharma And RHB-104: It Takes Guts To Achieve Success

RedHill Biopharma And RHB-104: It Takes Guts To Achieve Success.....»»

Category: topSource: seekingalphaNov 1st, 2018

RedHill Biopharma (RDHL) Investor Presentation - Slideshow

RedHill Biopharma (RDHL) Investor Presentation - Slideshow.....»»

Category: topSource: seekingalphaOct 31st, 2018

RedHill Biopharma presents data showing MAP US study met primary endpoint

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 22nd, 2018

RedHill Biopharma to present Phase 3 Crohn"s disease study with RHB-104

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 10th, 2018

RedHill Biopharma announces meeting with FDA for Bekinda for IBS-D

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallSep 12th, 2018

RedHill Biopharma announces advancement to second stage of Yeliva study

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallSep 6th, 2018

RedHill Biopharma"s Drug Pipeline May Merit Substantial Upside, And Potential Catalysts Are On The Horizon

RedHill Biopharma"s Drug Pipeline May Merit Substantial Upside, And Potential Catalysts Are On The Horizon.....»»

Category: topSource: seekingalphaSep 4th, 2018

RedHill Biopharma Ltd. (RDHL) CEO Dror Ben-Asher on Q2 2018 Results - Earnings Call Transcript

RedHill Biopharma Ltd. (RDHL) CEO Dror Ben-Asher on Q2 2018 Results - Earnings Call Transcript.....»»

Category: topSource: seekingalphaAug 30th, 2018

RedHill Biopharma reports Q2 EPS (5c), consensus (45c)

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 30th, 2018

RedHill Biopharma Reports Second Quarter 2018 Financial Results and Provides Update on Operations

RedHill Biopharma Reports Second Quarter 2018 Financial Results and Provides Update on Operations.....»»

Category: earningsSource: benzingaAug 30th, 2018

RedHill Biopharma: Current Dip An Opportunity?

RedHill Biopharma: Current Dip An Opportunity?.....»»

Category: topSource: seekingalphaAug 28th, 2018

RedHill Biopharma receives notice of allowance from USPTO for RHB-106

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 20th, 2018

Your Daily Pharma Scoop: Redhill Receives NoA, Regeneron Gets CRL, Stemline NDA Under Review

Your Daily Pharma Scoop: Redhill Receives NoA, Regeneron Gets CRL, Stemline NDA Under Review.....»»

Category: topSource: seekingalphaAug 14th, 2018

RedHill Biopharma receives allowance from USPTO for new formulation pantent

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 13th, 2018

RedHill Biopharma 4.167M share Secondary priced at $6.00

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 9th, 2018